Log in to save to my catalogue

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a89c555d26e948cda00d25cc88e6a03b

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

About this item

Full title

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

Publisher

Switzerland: MDPI AG

Journal title

Antioxidants, 2021-01, Vol.10 (2), p.164

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Organophosphate compounds (OPs) interfere with neurodevelopment and are neurotoxic for humans and animals. They are first biotransformed to the more toxic oxon form, and then hydrolyzed to specific metabolites by the enzyme paraoxonase/arylesterase, encoded by the gene
located on human chr. 7q21.3. In autism spectrum disorder (ASD) and in attent...

Alternative Titles

Full title

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a89c555d26e948cda00d25cc88e6a03b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a89c555d26e948cda00d25cc88e6a03b

Other Identifiers

ISSN

2076-3921

E-ISSN

2076-3921

DOI

10.3390/antiox10020164

How to access this item